B. Mark Smithers

21.0k citations
250 papers · 11.8k · 6 hit papers · h-index 46

Impact in

  • Surgery top 0.1%
    • Esophageal Cancer Research and Treatment
    • Esophageal and GI Pathology
  • Oncology top 0.5%
    • Cutaneous Melanoma Detection and Management
    • CAR-T cell therapy research

Papers in

  • Oncology 118
    • Cutaneous Melanoma Detection and Management 88
    • Cancer Immunotherapy and Biomarkers 11
  • Surgery 94
    • Esophageal Cancer Research and Treatment 61
    • Esophageal and GI Pathology 19
Co-authors
Bryan Burmeister (40 shared papers)Val Gebski (12 shared papers)D. C. Gotley (45 shared papers)John Zalcberg (10 shared papers)Andrew P. Barbour (47 shared papers)R. J. Simes (2 shared papers)Janine Thomas (46 shared papers)Katrin Marie Sjoquist (1 shared paper)
Journals
Melanoma Research (16 papers)Journal of Clinical Oncology (14 papers)ANZ Journal of Surgery (14 papers)Annals of Surgical Oncology (13 papers)Journal of Surgical Oncology (8 papers)
Partner nations
AustraliaUnited KingdomUnited States

In The Last Decade

B. Mark Smithers

243 papers receiving 11.6k citations

B. Mark Smithers's Hit Papers

Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society Recommendations 2018 · 387 citations
3870+7+14Years since publication4008001.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

  • it has ≥500 total citations;
  • it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
  • it reaches the top citation threshold in at least one of its specific research topics.
  1. 2018 World Journal of Surgery
  2. 2015 Annals of Surgery
  3. 2014 New England Journal of Medicine
  4. 2011 The Lancet Oncology
  5. 2007 The Lancet Oncology
  6. 2005 The Lancet Oncology

Peers

B. Mark Smithers
Comparison fields: 5 of 150
  • Surgery 6.3k
  • Oncology 3.3k
  • Gastroenterology 615
  • Pulmonary and Respiratory Medicine 2.9k
  • Dermatology 309
Replace Paul F. Mansfield with:
Paul F. Mansfield United States
Janice N. Cormier United States
Cornelis Verhoef Netherlands
Edward A. Levine United States
John H. Donohue United States
Herman R. Menck United States
Elyn Riedel United States
Martin R. Weiser United States
Dirk Arnold Germany
Wilfried Budach Germany
B. Mark Smithers relative to Paul F. Mansfield United States Paul F. Mansfield's profile →
Citations per field
00.5×2×3.5×
Paul F. Mansfield · 1×
Citations per year

Countries citing papers authored by B. Mark Smithers

Since Specialization
Citations

This map shows the geographic impact of B. Mark Smithers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Mark Smithers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Mark Smithers more than expected).

Fields of papers citing papers by B. Mark Smithers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Mark Smithers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Mark Smithers. The network helps show where B. Mark Smithers may publish in the future.

Co-authors

The 25 scholars most cited alongside B. Mark Smithers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Mark Smithers Line = papers co-authored together B. Mark Smithers links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 250 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
The Lancet Oncology ·Katrin Marie Sjoquist, Bryan Burmeister, B. Mark Smithers, John Zalcberg, R. J. Simes, Andrew P. Barbour, Val Gebski
Hit paper breakdown →		20111245
2
Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma
New England Journal of Medicine ·Donald L. Morton, John F. Thompson, (unknown), Nicola Mozzillo, Omgo E. Nieweg, Daniel F. Roses, H.J. Hoekstra, Constantine P. Karakousis, Christopher A. Puleo, Brendon J. Coventry, Mohammed Kashani–Sabet, B. Mark Smithers, Eberhard Paul, William Kraybill, J. Gregory McKinnon, (unknown), Robert M. Elashoff, Mark B. Faries
Hit paper breakdown →		2014960
3
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis
The Lancet Oncology ·Val Gebski, Bryan Burmeister, B. Mark Smithers, Kerwyn Foo, John Zalcberg, John Simes
Hit paper breakdown →		2007914
4
International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy
Annals of Surgery ·Donald E. Low, Derek Alderson, Ivan Cecconello, Andrew C. Chang, Gail Darling, Xavier Benoît D’Journo, S M Griffin, Arnulf H. Hölscher, Wayne L. Hofstetter, Blair A. Jobe, Yuko Kitagawa, John C. Kucharczuk, Simon Ying Kit Law, (unknown), Nick Maynard, Manuel Pera, Jeffrey H. Peters, C.S. Pramesh, John V. Reynolds, B. Mark Smithers, J. Jan B. van Lanschot
Hit paper breakdown →		2015807
5
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
The Lancet Oncology ·Bryan Burmeister, B. Mark Smithers, Val Gebski, (unknown), R. J. Simes, Peter G. Devitt, Stephen P. Ackland, D. C. Gotley, David Joseph, Jeremy Millar, J. B. North, Euan Walpole, James W. Denham
Hit paper breakdown →		2005699
6
Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
World Journal of Surgery ·Donald E. Low, William Allum, Giovanni De Manzoni, Lorenzo Ferri, Arul Immanuel, MadhanKumar Kuppusamy, Simon Law, Mats Lindblad, Nick Maynard, Joseph M. Neal, C.S. Pramesh, Mike Scott, B. Mark Smithers, Valérie Addor, Olle Ljungqvist
Hit paper breakdown →		2018387
7
Comparison of the Outcomes Between Open and Minimally Invasive Esophagectomy
Annals of Surgery ·B. Mark Smithers, D. C. Gotley, Ian Martin, Janine Thomas
2007311
8
Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial
European Journal of Cancer ·Bryan Burmeister, Janine Thomas, Elizabeth Burmeister, Euan Walpole, Jennifer A. Harvey, Damien Thomson, Andrew P. Barbour, D. C. Gotley, B. Mark Smithers
2010243
9
Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus
Gut ·David C. Whiteman, Shahram Sadeghi, Nirmala Pandeya, B. Mark Smithers, D. C. Gotley, Christopher Bain, Penelope M. Webb, Adèle C. Green, (unknown)
2007220
10
AUSTRALASIAN GASTRO-INTESTINAL TRIALS GROUP. SURVIVAL BENEFI TS FROM NEOADJUVANT CHEMORADIOTHERAPY OR CHEMOTHERAPY IN OESOPHAGEAL CARCINOMA: A META-ANALYSIS
Val Gebski, B. Burmeister, B. Mark Smithers
2007208
11
High rate of detection of primary aldosteronism, including surgically treatable forms, after ???non-selective??? screening of hypertensive patients
Journal of Hypertension ·Michael Stowasser, Richard D. Gordon, T. G. Gunasekera, Diane Cowley, Gregory J. Ward, Colin Archibald, B. Mark Smithers
2003200
12
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial
The Lancet Oncology ·Bryan Burmeister, Michael A. Henderson, Jill Ainslie, Richard Fisher, Juliana Di Iulio, B. Mark Smithers, Angela Hong, Kerwin F. Shannon, Richard A. Scolyer, Scott Carruthers, Brendon J. Coventry, Scott Babington, (unknown), Harald J. Hoekstra, John F. Thompson
2012185
13
Trends for in situ and Invasive Melanoma in Queensland, Australia, 1982–2002
Cancer Causes & Control ·Michael Coory, Peter D. Baade, Joanne F. Aitken, B. Mark Smithers, G. Roderick McLeod, Ian Ring
2006180
14
Laparoscopic versus Open Appendectomy: Prospective Randomized Trial
World Journal of Surgery ·John Brendan Hansen, B. Mark Smithers, David Schache, (unknown), Brian J. Miller, B Menzies
1996154
15
TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG
Annals of Surgical Oncology ·Trevor Leong, B. Mark Smithers, Karin Haustermans, Michael Michael, Val Gebski, Danielle Miller, John Zalcberg, Alex Boussioutas, Michael Findlay, Rachel O’Connell, Jaclyn Verghis, David J. Willis, Tomas Kron, (unknown), William K. Murray, Florian Lordick, Carol J. Swallow, Gail Darling, John Simes, Rebecca Wong
2017154
16
Factors Associated with Postoperative Pulmonary Morbidity After Esophagectomy for Cancer
Annals of Surgical Oncology ·Urs Zingg, B. Mark Smithers, D. C. Gotley, Garett Smith, Ahmad Aly, (unknown), (unknown), Glyn G. Jamieson, David I. Watson
2010137
17
Laparoscopic Nissen fundoplication--200 consecutive cases.
Gut ·D. C. Gotley, B. Mark Smithers, M Rhodes, B Menzies, Frank J. Branicki, Katherine L. Nathanson
1996136
18
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial
The Lancet Oncology ·Michael A. Henderson, Bryan Burmeister, Jill Ainslie, Richard Fisher, Juliana Di Iulio, B. Mark Smithers, Angela Hong, Kerwin F. Shannon, Richard A. Scolyer, Scott Carruthers, Brendon J. Coventry, Scott Babington, (unknown), Harald J. Hoekstra, John F. Thompson
2015136
19
Metastasectomy for Distant Metastatic Melanoma: Analysis of Data from the First Multicenter Selective Lymphadenectomy Trial (MSLT-I)
Annals of Surgical Oncology ·John H. Howard, John F. Thompson, Nicola Mozzillo, Omgo E. Nieweg, Harald J. Hoekstra, Daniel F. Roses, Vernon K. Sondak, Douglas S. Reintgen, Mohammed Kashani–Sabet, Constantine P. Karakousis, Brendon J. Coventry, William Kraybill, B. Mark Smithers, Robert M. Elashoff, Stacey L. Stern, Alistair J. Cochran, Mark B. Faries, Donald L. Morton
2012126
20
Implementing a waste management plan during the construction phase of a project: a case study
Construction Management and Economics ·Bruce Beresford McDonald, B. Mark Smithers
1998118

About B. Mark Smithers

B. Mark Smithers is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Molecular Biology and Gastroenterology, having authored 250 papers that have together received 11.8k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (88 papers), Esophageal Cancer Research and Treatment (61 papers), Gastric Cancer Management and Outcomes (29 papers), Melanoma and MAPK Pathways (20 papers), Esophageal and GI Pathology (19 papers), Immunotherapy and Immune Responses (12 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Gastroesophageal reflux and treatments (11 papers). The work is most often cited by research in Surgery (6.3k citations), Oncology (3.3k citations), Gastroenterology (615 citations), Pulmonary and Respiratory Medicine (2.9k citations) and Dermatology (309 citations). B. Mark Smithers has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Bryan Burmeister, Val Gebski, D. C. Gotley, John Zalcberg, Andrew P. Barbour, R. J. Simes, Janine Thomas, Katrin Marie Sjoquist, John Simes and Kerwyn Foo. Their work appears in journals such as Melanoma Research, Journal of Clinical Oncology, ANZ Journal of Surgery, Annals of Surgical Oncology and Journal of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul F. MansfieldBreakdown of academic impact, for papers by Janice N. CormierBreakdown of academic impact, for papers by Cornelis VerhoefBreakdown of academic impact, for papers by Edward A. LevineBreakdown of academic impact, for papers by John H. DonohueBreakdown of academic impact, for papers by Herman R. MenckBreakdown of academic impact, for papers by Elyn RiedelBreakdown of academic impact, for papers by Martin R. WeiserBreakdown of academic impact, for papers by Dirk ArnoldBreakdown of academic impact, for papers by Wilfried Budach